News

From October 31st to November 2nd ADAMED participated in BIO-Europe 2011 – the largest European biopartnering conference. This-year event, taking place in Duesseldorf, gathered nearly three thousands delegates from more than 1.5 thousand pharmaceutical and biotech companies, investment funds and R&D service providers.
During the three-day conference our delegates have participated in several dozen bilateral meetings with representatives of pharma and biotech companies. They also attended numerous panel discussions and presentations related to current trends in pharmaceutical deal-making.
Active participation in biopharmaceutical partnering conferences is an important element of ADAMED’s drug discovery, development and commercialization strategy. Our presence at the subsequent edition of BIO-Europe was an opportunity to present our newest research findings within the international business environment. In the upcoming months we hope to build upon the newly established relations.